Usefulness of individual support and medication for autism spectrum disorder traits in a boy with cyclic vomiting syndrome

DOI
  • Mori Tatsuo
    Department of Pediatrics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima
  • Goji Aya
    Department of Pediatrics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima
  • Toda Yoshihiro
    Department of Pediatrics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima
  • Okada Asami
    Department of Pediatrics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima
  • Kotani Yumiko
    Department of Pediatrics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima
  • Kagami Shoji
    Department of Pediatrics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima

Bibliographic Information

Other Title
  • 自閉スペクトラム症の特性に応じた個別支援と薬物治療が有用であった周期性嘔吐症の男児例

Search this article

Abstract

<p>  Herein we report the case of a 7-year-old boy with cyclic vomiting syndrome (CVS) successfully treated with judicious management and medication of autism spectrum disorder (ASD) traits. Radical surgery for esophageal atresia (Gross C) was performed during the neonatal period. The patient’s mother and grandmother both had migraines. The cyclic vomiting began when he was 1 year and 4 months of age, and the episodes occurred 1-3 times monthly. Various drug treatments were tested, but were not effective in controlling the vomiting events. The patient was referred to our hospital at the age of 7 years and 4 months for consultation and treatment. We arrived at a diagnosis of ASD due to observable traits including avoidance of eye contact, obsessiveness, and difficulty in communication. Subsequently, we began individual support and medication for ASD traits to alleviate the CVS. The school has begun to support for his behaviors associated with ASD. Consequently, the psychological anxiety regarding school attendance was addressed, allowing the patient to return to school. When prophylactic drug treatment was changed to the combination of risperidone, amitriptin, and sodium valproate, the vomiting attacks discontinued. The patient is now aged 9 years and 3 months, and has experienced no recurrent vomiting episodes in the past 14 months. In conclusion, it is important to consider the possible coexistence of developmental disorders in patients with intractable CVS, and to provide the reasonable accommodation and treatment for optimal outcomes.</p>

Journal

  • NO TO HATTATSU

    NO TO HATTATSU 53 (1), 54-57, 2021

    The Japanese Society of Child Neurology

Keywords

Details 詳細情報について

Report a problem

Back to top